Aldeyra The (ALDX) vs Celularity Inc. (CELU)

A side-by-side comparison of Aldeyra The and Celularity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALDX vs CELU

growth of $100 · dividends reinvested · last 7y
ALDX -82.6% (-22.1%/yr)CELU -98.3% (-43.9%/yr)ALDX compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$17$2
ALDX CELU

ALDX vs CELU: by the numbers

  • •ALDX is the larger company ($55M vs $46M market cap).
  • •Both run net losses; ALDX's is the smaller (0.00% vs -375.77% net margin).

Metrics side by side

Valuation

MetricALDXCELU
P/S ratioN/A2.41
P/B ratio1.46N/A

Profitability

MetricALDXCELU
Gross margin0.00%79.62%
Operating margin0.00%-230.92%
Net margin0.00%-375.77%
ROE-60.85%N/A
ROIC-63.52%-192.99%

Growth (annualized)

MetricALDXCELU
Revenue CAGR (5Y)N/A8.31%
Total return CAGR (5Y)-36.54%-52.57%

Frequently asked

How have ALDX and CELU total returns compared?
Over the past 5 years, ALDX delivered -36.54% and CELU delivered -52.57% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.